Season 1

Exploring Treating Covid 19 Through Cell Signalling

In this interview Dr. Lorne Brown and Dr. John McMichaels speak about the clinical studies on COVID-19 with a new product called TML. It is a viral product built to work with cells signaling. TML works in a way that brings the body back into balance providing all the bodies mechanisms are there and available at the cellular level.

This product is not a cure but meant to catch the disease early so a person does not end up in the hospital.




Start – Dr. John McMichael introduction

2:31 mins – Discussing clinical trial for COVID-19

4:00 mins – Discussing cell signalling and explaining how it works

6:17 mins – How resonant molecular signalling impacts disease and health

8:21 mins – Discussing being able to help ‘long haulers’

9:45 mins – Discussing severe reactions and being hospitalized

10:12 mins- Discussing TML with recurrent oral herpes infections

11:38 mins – Discussing other products in the works

12:53 mins- Discussing the mechanism for brain injury

15:00 mins – Discussing the mechanisms for anxiety and depression and creating the product

16:35 mins – Discussing micro-dosing and hormesis

19:18 mins – Discussing the success rate with the TML

20:09 mins – Discussing why it doesn’t work for everyone

22:05 mins – Discussing Phase 3 with TML and when it should be expected

24:28 mins – Mentioning donations and investing

25:00 mins – Discussing continued research on anxiety and depression TML

25:14 mins – Discussing the material in products used and safety issues

29:11 mins – Discussing if you can take the product prophetically

30:08 mins – Closing off the interview with Dr. John McMichael












Hosts & Guests

Lorne Brown

John McMichael

Share Episode




About the Speaker

John McMichael, Ph.D., President & CEO

Dr. McMichael received his B.S. in Microbiology from the University of Maine and his Ph.D. from Oregon State University in Immunology and Virology, and did his post-doctoral work at the Wistar Institute in Philadelphia, PA. He developed the world’s first live-virus fish vaccines for use in fish populations, and is an Alzheimer’s disease pioneer, having licensed 30+ patents to Elan Corp. plc, to support their Alzheimer’s initiative. He now holds more than 200 patents worldwide. His experience also includes:

  • Professor of Biology and Health Sciences, Edinboro University of Pennsylvania;
  • General Manager for ImmunoTherapeutics, where he licensed a veterinary anti-inflammatory product to Eudomonics, Inc., which launched and continues to sell the product;
  • Vice President of Molecular Rx, Inc., a biopharmaceutical company focused on products for managing inflammatory responses;
  • Founder and President of Milkhaus Laboratory, Inc., a company now focused on botanical agents for nutraceutical use;
  • Founder and President of The Institute for Therapeutic Discovery, a not-for-profit organization focusing on the interplay between biochemistry and biophysics in the course and management of health and disease.


Select your currency
USD United States (US) dollar